| Amoxicillin-Clavulanate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Amoxicillin-Clavulanate 500 mg-125 mg | tablet | oral | 1.0 each | OTC |
| Amoxicillin-Clavulanate 875 mg-125 mg | tablet | oral | 1.0 each | OTC |
| Amoxicillin-Clavulanate 500 mg-125 mg | tablet | oral | 1.0 each | OTC |
| Amoxicillin-Clavulanate 250 mg-125 mg | tablet | oral | 1.0 each | OTC |
| Amoxicillin-Clavulanate 600 mg-42.9 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Amoxicillin-Clavulanate 600 mg-42.9 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Amoxicillin-Clavulanate 400 mg-57 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Amoxicillin-Clavulanate 200 mg-28.5 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Amoxicillin-Clavulanate 400 mg-57 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Amoxicillin-Clavulanate 200 mg-28.5 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
Antibiotics Found Ineffective for Middle Ear Effusion - MedPage Today
Amoxicillin was the antibiotic used in each of the five trials (amoxicillin-clavulanate in one). Amoxicillin was compared with placebo in four and delayed ...
Tue Feb 19 13:41:15 -0500 2008
Antibiotic and Steroid Therapy Do Not Significantly Influence ... - Medi News Direct
Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. ...
Wed Dec 12 15:34:42 -0500 2007
Acute Sinusitis—To Treat or Not to Treat? - Journal of American Medical Association (subscription)
Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. ...
Tue Dec 04 15:57:43 -0500 2007
amoxicillin (as trihydrate)
clavulanate potassium - A semi-synthetic beta-lactamase inhibitor isolated from streptomyces. Clavunalate potassium contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site. This protects other beta-lactam antibiotics from beta-lactamase catalysis. This drug is used in conjunction with beta-lactamase susceptible penicillins to treat infections caused by beta-lactamase producing organisms.